G. Mehta, K. Islam / Tetrahedron Letters 44 (2003) 6733–6736
6735
The hydroxy-acetate (+)-8 was oxidized to the acetoxy-
ketone (−)-13 and Lombardo methylenation9 led to the
terminal olefin (+)-14 (Scheme 4). Acetate deprotection
in 14 delivered the desired key intermediate (−)-4.10
Following the synthetic sequence outlined in Scheme 2
for the synthesis of (+)-ottelione A 1, (−)-4 was elabo-
rated to (−)-ottelione A 1 (ent-ottelione A), [h]D −17 (c
0.4, CHCl3), Scheme 5. Finally, (−)-ottelione A 1 was
epimerized with DBU to furnish (+)-ottelione B 2 (ent-
ottelione B), [h]D +246 (c 0.4, CHCl3), Scheme 6.5
In short, we have outlined enantioselective syntheses of
both the enantiomers of otteliones A and B from the
Diels–Alder adduct 3 of cyclopentadiene and p-benzo-
quinone, following an enantiodivergent strategy. Our
synthetic studies have established the absolute configu-
ration of the naturally occurring otteliones A and B as
(+)-1 and (−)-2, respectively.
Scheme 4. Reagents and conditions: (a) PDC, DCM, 0°C,
80%; (b) Zn-TiCl4-CH2Br2, DCM, 0°C, 76%; (c) K2CO3,
MeOH, 0°C, quant.
Acknowledgements
K.I. thanks CSIR, India for the award of a research
fellowship. This work was supported by the Chemical
Biology Unit of JNCASR at the Indian Institute of
Science, Bangalore. The lipase used in this study was a
gift from Dr. Y. Hirose of Amano Pharmaceutical Co.
Ltd, Japan.
References
1. (a) Ayyad, S. E. N.; Judd, A. S.; Shier, W. T.; Hoye, T.
R. J. Org. Chem. 1998, 63, 8102; (b) Combeau, C.;
Provost, J.; Lanceli, F.; Tournoux, Y.; Prod’homme, F.;
Herman, F.; Lavelle, F.; Leboul, J.; Vuilhorgne, M. Mol.
Pharm. 2000, 57, 553.
2. (a) Li, H.; Li, H.; Qu, X.; Shi, Y.; Guo, L.; Yuan, Z.
Zhongguo Zhongyao Zazhi (Chin. J. Chin. Mat. Med.)
1995, 20, 128; (b) Leboul, J.; Prevost, J. French Patent
WO96/00205, 1996 (Chem. Abstr. 1996, 124, 242296).
3. (a) Mehta, G.; Reddy, D. S. Chem. Commun. 1999, 2193;
(b) Mehta, G.; Islam, K. Synlett 2000, 1473; (c) Trem-
bleau, L.; Patiny, L.; Ghosez, L. Tetrahedron Lett. 2000,
41, 6377; (d) Mehta, G.; Islam, K. Org. Lett. 2002, 4,
2881; (e) Clive, D. L. J.; Fletcher, S. P. Chem. Commun.
2002, 1940; (f) Hoye, T. R., private communication.
4. Mehta, G.; Islam, K. Angew. Chem., Int. Ed. Engl. 2002,
41, 2396.
Scheme 5. Reagents and conditions: (a) i. O3, MeOH, −78°C,
n
ii. Me2S, rt 70%; (b) Ph3PCH3+I−, BuLi, THF, 0°C, 85%; (c)
5. The two full papers1a,b dealing with the structure elucida-
tion of otteliones do not report the specific rotation of
these natural products. However, in response to our
queries, Professor Hoye from the University of
Minnesota1a informed us that the two samples of otte-
lione A isolated by his group exhibited specific rotations
of +22 (c 1.25, CDCl3) and +14 (c 0.87, CHCl3), respec-
tively. On the other hand, Dr. H. Bouchard of Aventis
(formerly RPR)1b informed us that their sample of otte-
lione A had a specific rotation of −20.8 (c 0.5, CH2Cl2).
This was quite intriguing and spurred us to undertake the
total synthesis of both the enantiomers of ottelione A.
Professor Hoye has also informed us that a sample of
ottelione B prepared by them had a rotation of −276 (c
2.0, CHCl3). We are most grateful to Professor Hoye and
Dr. Bouchard for information regarding the rotations of
otteliones.
PCC, DCM, 0°C, 91%; (d) 4-bromo-1-methoxy-2-(tert-
n
butyldimethylsiloxy)benzene, BuLi, THF, −78°C–rt, 87%; (e)
Li, liq. NH3, THF, −33°C, 85%; (f) PCC, DCM, 0°C, 86%;
(g) i. LHMDS, PhSeCl, THF, −78°C; ii. 30% H2O2, DCM,
0°C, 68% (two steps); (h) TBAF, THF, 0°C, 77%.
Scheme 6. Reagents and conditions: (a) DBU, benzene, 65°C,
81%.